Intracranial Hematoma and Brain Abscess

Intracranial hematoma and brain abscess are two distinct but often overlapping neurosurgical conditions characterized by the accumulation of blood (hematoma) or pus (abscess) within the cranial vault, leading to progressive neurological dysfunction due to mass effect, increased intracranial pressure (ICP), and potential brain herniation. Intracranial hematomas are classified by their anatomical location: epidural (between the dura mater and skull), subdural (between the dura and arachnoid), subarachnoid (within the subarachnoid space), intraparenchymal (within the brain parenchyma), and intraventricular (within the ventricular system). Brain abscesses are focal, encapsulated collections of pus within the brain parenchyma, typically arising from contiguous spread (e.g., otitis media/interna, sinusitis), hematogenous dissemination (bacterial endocarditis, dental disease), or direct inoculation (penetrating trauma, neurosurgery). Both conditions are surgical emergencies when they cause significant mass effect or neurological deterioration. The surgical management involves craniectomy or craniotomy for evacuation of the hematoma or abscess, with meticulous hemostasis and debridement, followed by appropriate medical therapy (antimicrobials, anticonvulsants, ICP management). The prognosis depends on the etiology, location, size, rapidity of onset, and the patient's neurological status at presentation.

Intracranial hematomas in dogs and cats most commonly result from traumatic brain injury (TBI), such as vehicular trauma, falls, or bite wounds, leading to rupture of meningeal or cerebral vessels. Epidural hematomas are often associated with skull fractures, particularly of the temporalis or parietal bones, causing laceration of the middle meningeal artery or venous sinuses. Subdural hematomas arise from tearing of bridging veins between the brain and dura, often due to acceleration-deceleration injuries. Intraparenchymal hematomas can occur from contusional hemorrhage or from rupture of vascular anomalies (e.g., arteriovenous malformations, aneurysms) or neoplasms (e.g., metastatic hemangiosarcoma). Spontaneous intracranial hemorrhage may also occur secondary to systemic hypertension, coagulopathies (e.g., rodenticide toxicity, thrombocytopenia, von Willebrand disease), or inflammatory conditions (e.g., steroid-responsive meningitis-arteritis). Brain abscesses are most frequently caused by bacterial infections, with common isolates including Staphylococcus spp., Streptococcus spp., Escherichia coli, Pasteurella multocida, and anaerobic organisms (Bacteroides, Fusobacterium). The most common routes of infection are: (1) contiguous spread from otitis media/interna, sinusitis, or dental infections; (2) hematogenous dissemination from distant sites (e.g., bacterial endocarditis, pneumonia, skin infections); (3) direct inoculation from penetrating foreign bodies (e.g., grass awns, bullets) or iatrogenic during neurosurgery; and (4) extension from a foreign body migration (e.g., plant material). Fungal abscesses (e.g., Cryptococcus, Aspergillus) are less common but occur in immunocompromised patients or endemic regions.

Intracranial hematomas and brain abscesses are relatively uncommon in small animal practice but represent life-threatening emergencies. Traumatic brain injury is the leading cause of intracranial hematomas in dogs and cats, with a higher incidence in young, male, outdoor animals. Breed predispositions for TBI include brachycephalic breeds (e.g., Bulldogs, Pugs) due to their skull conformation and increased risk of head trauma. Spontaneous intracranial hemorrhage is more common in older animals with hypertension or neoplasia; breeds such as Golden Retrievers, Boxers, and Bernese Mountain Dogs are predisposed to primary brain tumors (e.g., gliomas, meningiomas) that may hemorrhage. Coagulopathies, such as rodenticide toxicity, are more common in dogs with access to anticoagulant baits. Brain abscesses are often secondary to chronic otitis media/interna, particularly in breeds with pendulous ears (e.g., Cocker Spaniels, Basset Hounds) or brachycephalic breeds with stenotic ear canals. Hematogenous spread is more common in dogs with bacterial endocarditis, especially large-breed dogs (e.g., German Shepherds, Labrador Retrievers) with predisposing valvular disease. There is no strong sex predilection for brain abscesses, but age distribution is bimodal: young animals (due to otitis or congenital infections) and older animals (due to neoplasia or immunosuppression). Feline brain abscesses are less common but may occur secondary to bite wounds or sinusitis.

The pathophysiology of intracranial hematoma and brain abscess involves a cascade of events leading to progressive neurological deterioration. In hematomas, the initial hemorrhage creates a space-occupying lesion that expands, causing mechanical compression of adjacent brain tissue. The mass effect leads to increased intracranial pressure (ICP), which impairs cerebral perfusion pressure (CPP = MAP - ICP). As ICP rises, cerebral blood flow decreases, leading to ischemia and hypoxia. The brain's autoregulatory mechanisms are overwhelmed, resulting in cytotoxic and vasogenic edema. The release of hemoglobin breakdown products (e.g., heme, iron) triggers an inflammatory response, with activation of microglia and astrocytes, release of pro-inflammatory cytokines (TNF-α, IL-1β), and oxidative stress, exacerbating neuronal injury. In brain abscesses, the initial infection causes focal cerebritis, characterized by vascular congestion, edema, and infiltration of neutrophils. Over 1-2 weeks, a capsule of fibroblasts and glial cells forms, walling off the pus. The abscess expands, causing mass effect and perifocal edema. The release of bacterial toxins and proteolytic enzymes leads to tissue necrosis and liquefaction. Both conditions can lead to brain herniation, most commonly transtentorial (caudal displacement of the cerebrum under the tentorium cerebelli) or foramen magnum herniation, which is rapidly fatal. The systemic inflammatory response syndrome (SIRS) may develop, leading to multi-organ dysfunction. Seizures are common due to cortical irritation and can further increase ICP and metabolic demand.

Predisposing factors for intracranial hematoma include: (1) Traumatic brain injury, especially from vehicular trauma, falls, or bites; (2) Coagulopathies, including rodenticide toxicity (vitamin K antagonism), thrombocytopenia (immune-mediated, chemotherapy), hemophilia, and von Willebrand disease; (3) Systemic hypertension, often secondary to chronic kidney disease, hyperadrenocorticism, or pheochromocytoma; (4) Intracranial neoplasia, particularly vascular tumors (hemangiosarcoma) or metastatic lesions; (5) Vascular anomalies, such as arteriovenous malformations or aneurysms; (6) Age (older animals with cerebral amyloid angiopathy); (7) Breed (brachycephalic breeds with skull abnormalities). Predisposing factors for brain abscess include: (1) Chronic otitis media/interna, especially with gram-negative or anaerobic infections; (2) Dental disease, particularly periodontitis or tooth root abscesses; (3) Sinusitis or rhinitis; (4) Penetrating foreign bodies (grass awns, bullets) or trauma; (5) Immunosuppression (e.g., corticosteroid therapy, feline leukemia virus, feline immunodeficiency virus); (6) Hematogenous spread from endocarditis, pneumonia, or skin infections; (7) Prior neurosurgery or craniotomy; (8) Brachycephalic conformation with stenotic ear canals and eustachian tube dysfunction.

Clinical signs of intracranial hematoma and brain abscess are variable and depend on the location, size, and rate of expansion. Common signs include: (1) Altered mentation, ranging from lethargy to stupor or coma; (2) Seizures, which may be focal or generalized; (3) Circling, head pressing, or behavioral changes; (4) Cranial nerve deficits, such as anisocoria, absent pupillary light reflex, strabismus, facial nerve paralysis, or vestibular signs (head tilt, nystagmus); (5) Proprioceptive deficits, hemiparesis, or tetraplegia; (6) Postural deficits, such as decerebrate rigidity (opisthotonos, extensor rigidity) or decerebellate posture; (7) Pain on palpation of the head or neck; (8) Fever, especially in brain abscess; (9) Signs of increased ICP, including bradycardia, hypertension, and respiratory abnormalities (Cushing's reflex); (10) In severe cases, signs of brain herniation, such as fixed and dilated pupils, loss of gag reflex, and respiratory arrest. The onset may be acute (hematoma) or subacute to chronic (abscess). Neurological examination should include assessment of mentation, cranial nerves, postural reactions, and spinal reflexes. The Modified Glasgow Coma Scale (MGCS) is useful for grading severity and predicting prognosis in traumatic brain injury.

Differential diagnoses for intracranial hematoma and brain abscess include: (1) Intracranial neoplasia (meningioma, glioma, choroid plexus tumor, metastatic carcinoma) – distinguished by progressive course, MRI findings (contrast enhancement, peritumoral edema), and histopathology; (2) Cerebrovascular accident (ischemic stroke) – acute onset, MRI shows restricted diffusion on DWI, no mass effect; (3) Inflammatory/infectious meningoencephalitis (e.g., granulomatous meningoencephalomyelitis, necrotizing meningoencephalitis, infectious meningitis) – CSF analysis shows pleocytosis, MRI shows multifocal lesions, response to immunosuppressive or antimicrobial therapy; (4) Hydrocephalus – congenital or acquired, MRI shows ventriculomegaly, signs may be intermittent; (5) Brain herniation due to other causes – e.g., severe edema from metabolic disease (hepatic encephalopathy) – history, blood work; (6) Toxicity (e.g., lead, metaldehyde) – history of exposure, blood lead levels; (7) Idiopathic epilepsy – normal interictal examination, no structural lesion on MRI; (8) Vestibular syndrome (peripheral or central) – may mimic brainstem signs, but MRI and CSF are normal in peripheral; (9) Trauma without hemorrhage – CT/MRI may show contusions but no discrete hematoma; (10) Abscess vs. tumor – MRI with diffusion-weighted imaging (DWI) and MR spectroscopy can help differentiate; abscess shows restricted diffusion and ring enhancement.

The diagnostic algorithm for suspected intracranial hematoma or brain abscess begins with a thorough history and physical examination, including neurological assessment and Modified Glasgow Coma Scale (MGCS). Emergency stabilization (ABCs: airway, breathing, circulation) is prioritized. If the patient is stable, the following steps are recommended: (1) Complete blood count, serum biochemistry, and coagulation profile (PT/aPTT, platelet count, buccal mucosal bleeding time) to identify coagulopathies or systemic disease; (2) Blood pressure measurement to assess for hypertension; (3) Thoracic radiographs to rule out metastatic disease or trauma; (4) Advanced imaging: MRI is the gold standard for brain abscess and hematoma, as it provides superior soft tissue contrast. CT is faster and more sensitive for acute hemorrhage and skull fractures. MRI sequences include T1-weighted, T2-weighted, FLAIR, DWI, and post-contrast T1-weighted. Hematomas have characteristic signal intensity changes over time (hyperacute: T1 iso/hypo, T2 hyper; acute: T1 iso/hypo, T2 hypo; subacute: T1 hyper, T2 hyper; chronic: T1 hypo, T2 hypo). Abscesses show a ring-enhancing lesion with central restricted diffusion on DWI. (5) CSF analysis is contraindicated if increased ICP is suspected due to risk of herniation; if performed, it may show neutrophilic pleocytosis and elevated protein in abscess, but is often normal in hematoma. (6) Electroencephalography (EEG) may be used to evaluate for seizure foci. (7) Surgical exploration and biopsy/aspiration may be necessary for definitive diagnosis and treatment. The decision to perform surgery is based on the presence of a surgically accessible lesion causing mass effect, progressive neurological deterioration, or failure of medical management.

Laboratory findings in intracranial hematoma and brain abscess are non-specific but may support the diagnosis and identify underlying causes. Complete blood count may reveal leukocytosis with a left shift in brain abscess, or thrombocytopenia in coagulopathy-associated hematoma. Serum biochemistry may show elevated liver enzymes (if hepatic encephalopathy), hyperglycemia (stress), or azotemia (renal disease). Coagulation panel (PT, aPTT, fibrinogen, D-dimer) is essential to rule out coagulopathy; prolonged PT/aPTT suggests rodenticide toxicity or liver disease. Platelet count and buccal mucosal bleeding time assess platelet function. Blood gas analysis may reveal hypoxemia or acid-base imbalances. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated in abscess. Blood cultures are recommended if bacteremia is suspected. CSF analysis, if performed, typically shows neutrophilic pleocytosis (100-1000 cells/µL) with elevated protein (50-200 mg/dL) and normal glucose in abscess; in hematoma, CSF may be normal or show xanthochromia with elevated protein. Cytology of CSF may reveal bacteria (gram stain) or fungal organisms. Polymerase chain reaction (PCR) for infectious agents (e.g., Cryptococcus, Toxoplasma, Neospora) can be performed on CSF. Urinalysis may reveal proteinuria or casts in hypertensive or vasculitic conditions.

Imaging is crucial for diagnosis and surgical planning. Radiography of the skull is of limited value but may show skull fractures, osteomyelitis, or foreign bodies. Ultrasonography through a craniectomy defect or fontanelle (in neonates) can identify intracranial masses but is rarely used. Computed tomography (CT) is the preferred modality for acute hemorrhage due to its speed and sensitivity for blood. On CT, acute hematomas appear as hyperdense (white) masses, with mass effect and perilesional edema. Epidural hematomas are biconvex (lens-shaped) and do not cross suture lines; subdural hematomas are crescent-shaped and cross suture lines. Intraparenchymal hematomas are round/oval and may have a fluid-fluid level. CT with contrast can identify ring enhancement in abscesses. Magnetic resonance imaging (MRI) provides superior soft tissue detail and is essential for evaluating brain abscesses and chronic hematomas. On MRI, hematomas show characteristic signal changes depending on age: hyperacute (<24h): T1 iso/hypo, T2 hyper; acute (1-3 days): T1 iso/hypo, T2 hypo; early subacute (3-7 days): T1 hyper, T2 hypo; late subacute (7-14 days): T1 hyper, T2 hyper; chronic (>14 days): T1 hypo, T2 hypo. Brain abscesses appear as a well-defined ring-enhancing lesion on T1 post-contrast, with central hyperintensity on T2 and restricted diffusion on DWI (bright on DWI, dark on ADC). Magnetic resonance spectroscopy may show elevated lactate and amino acids in abscess. Magnetic resonance angiography (MRA) or CT angiography can identify vascular anomalies. Intraoperative ultrasound can be used to localize lesions during surgery. Advanced imaging also helps in surgical planning, including neuronavigation if available.

Cytology and histopathology are essential for definitive diagnosis, especially for brain abscess and to rule out neoplasia. Fine-needle aspiration (FNA) of an abscess during surgery yields purulent material that can be submitted for cytology, culture, and sensitivity. Cytology of the aspirate typically shows degenerate neutrophils, necrotic debris, and bacteria (intracellular or extracellular). Gram stain can classify bacteria as gram-positive or gram-negative. Histopathology of a biopsy or excised capsule reveals a central area of liquefactive necrosis surrounded by a capsule of fibrous tissue, neovascularization, and inflammatory infiltrate (neutrophils, macrophages, lymphocytes, plasma cells). Special stains (e.g., Gram, Giemsa, PAS) can identify bacteria or fungi. In hematomas, histopathology shows organized blood clot with hemosiderin-laden macrophages, gliosis, and neovascularization. If a vascular malformation or neoplasm is suspected, histopathology of the excised lesion is necessary. Immunohistochemistry may be used to characterize tumors (e.g., GFAP for gliomas, vimentin for meningiomas). Surgical biopsy should be performed with care to avoid hemorrhage and herniation. Intraoperative cytology (smear preparation) can provide rapid diagnosis and guide surgical decisions.

Treatment of intracranial hematoma and brain abscess requires a multimodal approach, including medical stabilization and surgical intervention. Medical management is initiated immediately and includes: (1) Oxygen supplementation to maintain SpO2 >95%; (2) Intravenous fluid therapy with isotonic crystalloids (e.g., Lactated Ringer's) at maintenance rates, avoiding overhydration; (3) Mannitol (0.5-1 g/kg IV over 15-20 minutes) or hypertonic saline (7.5% NaCl at 3-5 mL/kg IV) to reduce ICP; (4) Anticonvulsant therapy (e.g., levetiracetam 20 mg/kg IV q8h, or phenobarbital 2-4 mg/kg IV q12h) for seizures; (5) Analgesia (e.g., opioids such as fentanyl 2-5 µg/kg/h CRI, or methadone 0.2-0.5 mg/kg IV q4-6h); (6) Broad-spectrum antibiotics for abscess (e.g., ampicillin 22 mg/kg IV q8h, enrofloxacin 5-10 mg/kg IV q24h, and metronidazole 10-15 mg/kg IV q12h) pending culture; (7) Corticosteroids (e.g., dexamethasone 0.1-0.2 mg/kg IV q12h) are controversial but may be used for vasogenic edema in abscess; (8) Gastric protectants (e.g., pantoprazole 1 mg/kg IV q12h) to prevent stress ulcers. Surgical treatment is indicated for: (1) Large hematomas (>2 cm) causing mass effect or progressive neurological decline; (2) Abscesses that are surgically accessible and not responding to medical therapy; (3) Diagnostic biopsy. Surgical techniques include: (1) Craniectomy or craniotomy over the lesion, using a pneumatic burr and rongeurs; (2) Durotomy for subdural hematoma evacuation; (3) Aspiration and drainage of abscess using a needle or catheter; (4) Complete excision of the abscess capsule if well-encapsulated; (5) Evacuation of hematoma using suction and irrigation, with meticulous hemostasis using bipolar electrocautery, bone wax, or hemostatic agents (e.g., Gelfoam, Surgicel). Postoperative management includes continued ICP monitoring, anticonvulsants, antibiotics (for abscess, 4-8 weeks), and supportive care. Physical rehabilitation may be needed for neurological deficits.

The prognosis for intracranial hematoma and brain abscess is guarded to good, depending on several factors. For traumatic hematomas, the prognosis is better if the patient presents with a higher Modified Glasgow Coma Scale score (>12) and has a focal, surgically accessible lesion. Mortality rates for severe TBI with intracranial hemorrhage range from 20-50% in dogs. Epidural hematomas have a better prognosis than subdural or intraparenchymal hematomas if surgically evacuated early. Spontaneous hematomas due to coagulopathy or hypertension have a poorer prognosis due to underlying systemic disease. Brain abscesses have a fair to good prognosis if treated aggressively with surgery and appropriate antibiotics; survival rates of 70-90% have been reported. Negative prognostic indicators include: (1) Coma or decerebrate rigidity at presentation; (2) Absence of pupillary light reflexes; (3) Progressive neurological deterioration despite medical therapy; (4) Multifocal or brainstem lesions; (5) Severe systemic disease (e.g., sepsis, coagulopathy); (6) Fungal abscess (poor response to therapy); (7) Recurrence of abscess. Long-term neurological deficits (e.g., seizures, proprioceptive deficits, behavioral changes) may persist in 30-50% of survivors. Seizure disorders may require lifelong anticonvulsant therapy. Overall, early diagnosis and surgical intervention improve outcomes.

Postoperative follow-up is critical for monitoring recovery and detecting complications. Immediately after surgery, patients should be monitored in an intensive care unit for 24-72 hours, with continuous assessment of neurological status, vital signs, and ICP if available. Serial Modified Glasgow Coma Scale scores should be recorded. Blood pressure, heart rate, respiratory rate, and oxygen saturation should be monitored. Neurological examinations should be performed every 2-4 hours initially, then daily. Suture removal from the skin is typically 10-14 days postoperatively. Antibiotic therapy for brain abscess should be continued for 4-8 weeks, with regular monitoring of renal and hepatic function. Anticonvulsant levels (e.g., phenobarbital) should be monitored and adjusted to maintain therapeutic range (25-40 µg/mL). Repeat imaging (MRI or CT) is recommended at 4-8 weeks postoperatively to assess resolution of the lesion and rule out recurrence. For hematomas, imaging may be repeated at 2-3 months to confirm complete resolution. Physical rehabilitation, including physiotherapy, hydrotherapy, and balance exercises, should be initiated as soon as the patient is stable to improve neurological recovery. Long-term follow-up every 3-6 months is recommended for patients with residual deficits or seizure disorders. Owners should be educated on the signs of increased ICP (e.g., lethargy, vomiting, seizures) and the importance of immediate veterinary attention.

Clinical pearls: (1) Always assess the Modified Glasgow Coma Scale (MGCS) on presentation and serially; a score ≤8 indicates severe TBI and guarded prognosis. (2) In traumatic brain injury, avoid hypotension and hypoxia; maintain mean arterial pressure >80 mmHg. (3) Mannitol should be given as a bolus, not a CRI, and only if the patient is euvolemic; avoid in hypovolemic shock. (4) For brain abscess, obtain cultures before starting antibiotics if possible, but do not delay therapy in critical patients. (5) Use a ring curette or suction to gently evacuate abscess contents; avoid excessive manipulation to prevent rupture into the ventricles. (6) For epidural hematoma, control bleeding from the middle meningeal artery with bipolar cautery or bone wax. (7) Always perform a durotomy to inspect the subdural space for hematoma. (8) Use a hemostatic matrix (e.g., Surgicel, Gelfoam) in the surgical bed to prevent rebleeding. (9) Postoperative seizures are common; start anticonvulsants preoperatively or immediately postoperatively. (10) Consider a ventriculoperitoneal shunt if hydrocephalus develops. Pitfalls: (1) Performing a cisternal CSF tap in a patient with increased ICP can cause brain herniation and death; avoid if papilledema or asymmetric pupils. (2) Overhydration with IV fluids can worsen cerebral edema; use isotonic crystalloids at maintenance rates. (3) Using corticosteroids in traumatic hematoma is not recommended and may increase mortality. (4) Incomplete evacuation of an abscess capsule can lead to recurrence; if the capsule is adherent to vital structures, leave it and drain. (5) Failure to identify and treat an underlying coagulopathy before surgery can lead to fatal hemorrhage. (6) Inadequate antibiotic therapy (short duration or narrow spectrum) can result in relapse. (7) Delaying surgery in a patient with progressive neurological decline can lead to irreversible brain damage. (8) Not monitoring ICP postoperatively can miss dangerous elevations. (9) Using a high-speed burr without irrigation can cause thermal injury to the brain. (10) Not performing a CT or MRI before surgery can lead to incorrect surgical approach.

Perioperative drug protocols are based on Plumb's Veterinary Drug Handbook. Preoperative: (1) Antibiotics: Cefazolin 22 mg/kg IV q90min intraoperatively, or ampicillin 22 mg/kg IV q8h, enrofloxacin 5-10 mg/kg IV q24h, and metronidazole 10-15 mg/kg IV q12h for abscess. (2) Anticonvulsants: Levetiracetam 20 mg/kg IV q8h, or phenobarbital 2-4 mg/kg IV q12h (loading dose 16 mg/kg IV over 15-20 minutes if seizures). (3) Corticosteroids: Dexamethasone 0.1-0.2 mg/kg IV q12h for vasogenic edema (abscess). (4) Osmotic diuretics: Mannitol 0.5-1 g/kg IV over 15-20 minutes, or hypertonic saline 7.5% NaCl 3-5 mL/kg IV over 10-15 minutes. (5) Analgesics: Fentanyl 2-5 µg/kg/h CRI, or methadone 0.2-0.5 mg/kg IV q4-6h. (6) Gastric protectants: Pantoprazole 1 mg/kg IV q12h, or famotidine 0.5-1 mg/kg IV q12h. Postoperative: (1) Continue antibiotics for 4-8 weeks (abscess), adjust based on culture and sensitivity. (2) Continue anticonvulsants for at least 3-6 months; if no seizures, taper gradually over 2-3 months. (3) Analgesia: Transition to oral opioids (tramadol 2-5 mg/kg PO q8-12h) or NSAIDs (carprofen 2.2 mg/kg PO q12h) after 24-48 hours, but avoid NSAIDs if corticosteroids are used. (4) Continue gastric protectants for 7-14 days. (5) If coagulopathy is present, administer vitamin K1 2.5-5 mg/kg PO q12h for 4-6 weeks (rodenticide toxicity). (6) For fungal abscess, use fluconazole 5-10 mg/kg PO q12h or itraconazole 5-10 mg/kg PO q24h for 6-12 months. (7) For hypertension, amlodipine 0.1-0.2 mg/kg PO q24h. (8) For cerebral edema, continue mannitol as needed (q6-8h) for 24-48 hours, but monitor hydration and electrolytes. (9) For seizures refractory to levetiracetam/phenobarbital, add potassium bromide 20-30 mg/kg PO q12h (loading dose 400 mg/kg PO divided over 2-3 days). (10) Always adjust dosages for renal or hepatic impairment.

Evidence-based literature on intracranial hematoma and brain abscess in small animals is limited but growing. Key studies include: (1) Platt et al. (2001) evaluated the Modified Glasgow Coma Scale in dogs with head trauma and found that scores ≤8 were associated with poor outcome. (2) Dewey et al. (2007) reported successful surgical management of brain abscesses in dogs, with a survival rate of 80% when treated with craniectomy and antibiotics. (3) Sturges et al. (2006) described MRI findings in dogs with intracranial hemorrhage, noting that gradient echo sequences are sensitive for chronic hemorrhage. (4) A retrospective study by Syring et al. (2001) on traumatic brain injury in dogs found that 50% of dogs with intracranial hemorrhage had coagulopathy, emphasizing the need for coagulation testing. (5) A study by Radaelli et al. (2007) compared medical vs. surgical treatment for brain abscess in dogs and found that surgical drainage plus antibiotics resulted in faster recovery and lower mortality. (6) The ACVS (American College of Veterinary Surgeons) consensus statement on head trauma recommends early CT/MRI and surgical decompression for progressive neurological deterioration. (7) A meta-analysis by Boudreau et al. (2017) on anticonvulsant prophylaxis in dogs with head trauma found that levetiracetam reduced the incidence of early post-traumatic seizures. (8) A study by Lowrie et al. (2013) on intracranial epidural hematomas in dogs reported a good prognosis with surgical evacuation, with 80% of dogs returning to normal function. (9) Research by Kent et al. (2009) on brain abscesses in cats showed that Cryptococcus is a common cause, and treatment with fluconazole and surgical drainage was effective. (10) The Veterinary Neurosurgical Society (VNS) guidelines recommend neuronavigation and intraoperative ultrasound for precise localization of intracranial lesions. Overall, the literature supports aggressive surgical intervention for accessible lesions and appropriate antimicrobial therapy for abscesses, with careful monitoring of ICP and neurological status.